Natalia Shcherbakova to Female
This is a "connection" page, showing publications Natalia Shcherbakova has written about Female.
Connection Strength
0.196
-
Qasba NT, Wallace KF, Yu V, Capoccia KL, Goff SL, Shcherbakova N. Online survey of consumer awareness and perceptions of a Massachusetts law for 12-month supply of contraception. Contraception. 2023 12; 128:110138.
Score: 0.046
-
Shcherbakova N, Tereso G, Spain J, Roose RJ. Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder. Ann Pharmacother. 2018 05; 52(5):405-414.
Score: 0.031
-
Shcherbakova N, Tereso G. Clinical pharmacist home visits and 30-day readmissions in Medicare Advantage beneficiaries. J Eval Clin Pract. 2016 Jun; 22(3):363-8.
Score: 0.027
-
Shcherbakova N, Shepherd M. Community pharmacists, Internet and social media: an empirical investigation. Res Social Adm Pharm. 2014 Nov-Dec; 10(6):e75-e85.
Score: 0.023
-
Pesaturo K, Shcherbakova N, Mattison M, Greenwald J, Capoccia K. Predictors of HPV vaccine intention in nonmonogamous adults. J Am Pharm Assoc (2003). 2025 Sep-Oct; 65(5):102473.
Score: 0.013
-
Osmond D, Shcherbakova N, Huston S. Prestige and financial stability: motivating factors to pursue a doctor of pharmacy degree. Int J Pharm Pract. 2023 Mar 13; 31(1):95-101.
Score: 0.011
-
Qasba N, Wallace KF, Sopko J, Czajka J, Capoccia KL, Shcherbakova N, Goff SL. Twelve-month supply of short-acting contraception methods: Pharmacists' perspectives on implementation of new state law. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1296-1303.e2.
Score: 0.010
-
Mo Y, Shcherbakova N, Inman KL, Li WK, Kovalenko K, Rosenberg J, Orsini J, Truong J. Evaluation of Individualized Cefepime Dosing Strategy Using Population Pharmacokinetics. J Clin Pharmacol. 2022 03; 62(3):359-365.
Score: 0.010
-
Connaughton DM, Dai R, Owen DJ, Marquez J, Mann N, Graham-Paquin AL, Nakayama M, Coyaud E, Laurent EMN, St-Germain JR, Blok LS, Vino A, Kl?mbt V, Deutsch K, Wu CW, Kolvenbach CM, Kause F, Ottlewski I, Schneider R, Kitzler TM, Majmundar AJ, Buerger F, Onuchic-Whitford AC, Youying M, Kolb A, Salmanullah D, Chen E, van der Ven AT, Rao J, Ityel H, Seltzsam S, Rieke JM, Chen J, Vivante A, Hwang DY, Kohl S, Dworschak GC, Hermle T, Alders M, Bartolomaeus T, Bauer SB, Baum MA, Brilstra EH, Challman TD, Zyskind J, Costin CE, Dipple KM, Duijkers FA, Ferguson M, Fitzpatrick DR, Fick R, Glass IA, Hulick PJ, Kline AD, Krey I, Kumar S, Lu W, Marco EJ, Wentzensen IM, Mefford HC, Platzer K, Povolotskaya IS, Savatt JM, Shcherbakova NV, Senguttuvan P, Squire AE, Stein DR, Thiffault I, Voinova VY, Somers MJG, Ferguson MA, Traum AZ, Daouk GH, Daga A, Rodig NM, Terhal PA, van Binsbergen E, Eid LA, Tasic V, Rasouly HM, Lim TY, Ahram DF, Gharavi AG, Reutter HM, Rehm HL, MacArthur DG, Lek M, Laricchia KM, Lifton RP, Xu H, Mane SM, Sanna-Cherchi S, Sharrocks AD, Raught B, Fisher SE, Bouchard M, Khokha MK, Shril S, Hildebrandt F. Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. Am J Hum Genet. 2020 10 01; 107(4):727-742.
Score: 0.009
-
Mo Y, Shcherbakova N, Zeibeq J, Muzykovsky K, Li WK, Gasperino J. Clinical and economic impact of the use of dexmedetomidine for sedation in the intensive care unit compared to propofol. Int J Clin Pharm. 2020 Dec; 42(6):1419-1424.
Score: 0.009
-
Robinson E, Shcherbakova N, Backer L. Assessment of Pharmacy Manpower and Services in New England. J Pharm Pract. 2016 Dec; 29(6):549-555.
Score: 0.006